CRSP: CRISPR Therapeutics AG
今日CRSP汇率已更改-1.01%。当日,交易品种以低点49.36和高点51.05进行交易。
关注CRISPR Therapeutics AG动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CRSP新闻
- Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet
- CRISPR Therapeutics 任命 A. J. Silver 为首席财务官,即刻生效,接替 Raju Prasad
- CRISPR Therapeutics Appoints A. J. Silver CFO, Effective Immediately, Succeeding Raju Prasad
- CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know
- UBS Initiates Coverage On CRISPR Therapeutics with Neutral Rating, Announces Price Target of $52
- CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
- TEVA Gets FDA Nod for Weltruza as Once-Monthly LAI in Schizophrenia
- Roche Reports Positive Phase III Data on Eye Drug, FDA Accepts BLA
- Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock
- ARGX Stock Down on Stopping Late-Stage Autoimmune Disease Study
- AbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in Cancer
- Ultragenyx to Sell Rare Pediatric Disease PRV for $210M to Boost Cash
- Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
- CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade
- Cathie Wood在ARKK五年内下跌近15%、而QQQ飙升112%后遭质疑,强硬回击——称这是“错误的比较”
- Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison’
- Wall Street Bulls Look Optimistic About CRISPR Therapeutics (CRSP): Should You Buy?
- Undercovered Stocks: Vicor, Rayonier, Accenture And More
- Anthropic Just Made a CRISPR-Like Discovery. What It Actually Means for CRSP Stock Investors.
- Temporary Weakness in Intellia Stock Seems Like a Buying Opportunity
- CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
- Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress (NASDAQ:BEAM)
- CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why
- Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing (CRSP)
常见问题解答
CRSP股票今天的价格是多少?
CRISPR Therapeutics AG股票今天的定价为49.99。它在49.36 - 51.05范围内交易,昨天的收盘价为50.50,交易量达到2095。CRSP的实时价格图表显示了这些更新。
CRISPR Therapeutics AG股票是否支付股息?
CRISPR Therapeutics AG目前的价值为49.99。股息政策取决于公司,而投资者也会关注-21.46%和USD。实时查看图表以跟踪CRSP走势。
如何购买CRSP股票?
您可以以49.99的当前价格购买CRISPR Therapeutics AG股票。订单通常设置在49.99或50.29附近,而2095和-0.04%显示市场活动。立即关注CRSP的实时图表更新。
如何投资CRSP股票?
投资CRISPR Therapeutics AG需要考虑年度范围44.12 - 64.74和当前价格49.99。许多人在以49.99或50.29下订单之前,会比较-9.62%和。实时查看CRSP价格图表,了解每日变化。
CRISPR Therapeutics AG股票的最高价格是多少?
在过去一年中,CRISPR Therapeutics AG的最高价格是64.74。在44.12 - 64.74内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪CRISPR Therapeutics AG的绩效。
CRISPR Therapeutics AG股票的最低价格是多少?
CRISPR Therapeutics AG(CRSP)的最低价格为44.12。将其与当前的49.99和44.12 - 64.74进行比较,可以发现潜在的长期切入点。观看CRSP在图表上的实时走势以获取更多详细信息。
CRSP股票是什么时候拆分的?
CRISPR Therapeutics AG历史上曾经历过股票拆分。这些变化在公司行动后的、50.50和-21.46%中可见。
- 前一天收盘价
- 50.50
- 开盘价
- 50.01
- 卖价
- 49.99
- 买价
- 50.29
- 最低价
- 49.36
- 最高价
- 51.05
- 交易量
- 2.095 K
- 日变化
- -1.01%
- 月变化
- -9.62%
- 6个月变化
- -3.10%
- 年变化
- -21.46%
- 实际值
- 194 K
- 预测值
- 198 K
- 前值
- 200 K
- 实际值
- 1.728 M
- 预测值
- 1.723 M
- 前值
- 1.703 M
- 实际值
- 0.0%
- 预测值
- 0.0%
- 前值
- -0.1%
- 实际值
- 预测值
- 前值
- 1.955%